KRW 28400.0
(1.79%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 76.59 Billion KRW | 2.84% |
2022 | 74.48 Billion KRW | 13.53% |
2021 | 65.6 Billion KRW | 5.55% |
2020 | 62.15 Billion KRW | 14.88% |
2019 | 54.1 Billion KRW | 28.7% |
2018 | 42.03 Billion KRW | 19.58% |
2017 | 35.15 Billion KRW | 16.49% |
2016 | 30.17 Billion KRW | 0.0% |
2014 | 27.46 Billion KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 81.54 Billion KRW | 6.45% |
2024 Q2 | 87.04 Billion KRW | 6.74% |
2023 Q4 | 76.59 Billion KRW | -11.89% |
2023 FY | 76.59 Billion KRW | 2.84% |
2023 Q1 | 84.9 Billion KRW | 13.99% |
2023 Q2 | 88.12 Billion KRW | 3.8% |
2023 Q3 | 86.93 Billion KRW | -1.35% |
2022 Q2 | 67.48 Billion KRW | 1.93% |
2022 Q1 | 66.2 Billion KRW | 0.92% |
2022 FY | 74.48 Billion KRW | 13.53% |
2022 Q4 | 74.48 Billion KRW | 11.3% |
2022 Q3 | 66.91 Billion KRW | -0.84% |
2021 Q2 | 66.03 Billion KRW | 2.29% |
2021 Q4 | 65.6 Billion KRW | 0.07% |
2021 Q1 | 64.55 Billion KRW | 3.87% |
2021 FY | 65.6 Billion KRW | 5.55% |
2021 Q3 | 65.55 Billion KRW | -0.72% |
2020 FY | 62.15 Billion KRW | 14.88% |
2020 Q4 | 62.15 Billion KRW | 0.68% |
2020 Q3 | 61.73 Billion KRW | 3.41% |
2020 Q2 | 59.69 Billion KRW | 4.62% |
2020 Q1 | 57.05 Billion KRW | 5.47% |
2019 FY | 54.1 Billion KRW | 28.7% |
2019 Q1 | 42.4 Billion KRW | 0.87% |
2019 Q4 | 54.1 Billion KRW | 20.55% |
2019 Q3 | 44.87 Billion KRW | 6.22% |
2019 Q2 | 42.25 Billion KRW | -0.36% |
2018 FY | 42.03 Billion KRW | 19.58% |
2018 Q3 | 39.97 Billion KRW | 8.27% |
2018 Q2 | 36.91 Billion KRW | 3.93% |
2018 Q4 | 42.03 Billion KRW | 5.16% |
2018 Q1 | 35.52 Billion KRW | 1.05% |
2017 Q2 | 36.03 Billion KRW | 7.02% |
2017 Q4 | 35.15 Billion KRW | 2.21% |
2017 FY | 35.15 Billion KRW | 16.49% |
2017 Q1 | 33.66 Billion KRW | 11.57% |
2017 Q3 | 34.39 Billion KRW | -4.55% |
2016 Q3 | 29.14 Billion KRW | 0.0% |
2016 Q4 | 30.17 Billion KRW | 3.54% |
2016 FY | 30.17 Billion KRW | 0.0% |
2014 FY | 27.46 Billion KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
HLB Pharmaceutical Co., Ltd | 20.85 Billion KRW | -267.234% |
CMG Pharmaceutical Co., Ltd. | 15.87 Billion KRW | -382.484% |
Celltrion Pharm, Inc. | 100.42 Billion KRW | 23.723% |
Huons Global Co., Ltd. | 121.81 Billion KRW | 37.121% |
DongKook Pharmaceutical Co., Ltd. | 138.34 Billion KRW | 44.632% |
Enzychem Lifesciences Corporation | 14.94 Billion KRW | -412.503% |
Humedix Co., Ltd. | 28.62 Billion KRW | -167.588% |
Boditech Med Inc. | 31.6 Billion KRW | -142.376% |
EuBiologics Co., Ltd. | 13.34 Billion KRW | -474.133% |
FutureChem Co.,Ltd | 1.37 Billion KRW | -5472.774% |
BNC Korea Co., Ltd. | 11.39 Billion KRW | -572.298% |
AptaBio Therapeutics Inc. | - KRW | -Infinity% |